Literature DB >> 31634007

Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Cardiovascular Studies.

Zachary R McCaw1, Guosheng Yin2, Lee-Jen Wei1.   

Abstract

Keywords:  coronary artery disease; follow-up studies; heart failure; probability

Year:  2019        PMID： 31634007     DOI： 10.1161/CIRCULATIONAHA.119.040680

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  13 in total

1.  Combining TMEM Doorway Score and MenaCalc Score Improves the Prediction of Distant Recurrence Risk in HR+/HER2- Breast Cancer Patients.

Authors:  Xianjun Ye; Maja H Oktay; Xiaonan Xue; Thomas E Rohan; Paula S Ginter; Timothy D'Alfonso; Elizabeth N Kornaga; Don G Morris; David Entenberg; John S Condeelis
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

2.  Are restricted mean survival time methods especially useful for noninferiority trials?

Authors:  Boris Freidlin; Chen Hu; Edward L Korn
Journal:  Clin Trials       Date:  2021-02-24       Impact factor: 2.486

3.  Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study.

Authors:  Edouard L Fu; Marie Evans; Catherine M Clase; Laurie A Tomlinson; Merel van Diepen; Friedo W Dekker; Juan J Carrero
Journal:  J Am Soc Nephrol       Date:  2020-12-28       Impact factor: 10.121

4.  The restricted mean survival time as a replacement for the hazard ratio and the number needed to treat in long-term studies.

Authors:  Andrea Messori; Laura Bartoli; Sabrina Trippoli
Journal:  ESC Heart Fail       Date:  2021-03-17

5.  On restricted mean time in favor of treatment.

Authors:  Lu Mao
Journal:  Biometrics       Date:  2021-09-25       Impact factor: 2.571

6.  Early combination of albumin with crystalloids administration might be beneficial for the survival of septic patients: a retrospective analysis from MIMIC-IV database.

Authors:  Shiyu Zhou; Zhenhua Zeng; Hongxia Wei; Tong Sha; Shengli An
Journal:  Ann Intensive Care       Date:  2021-03-10       Impact factor: 6.925

7.  Serum Galectin-3 levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study.

Authors:  Shuxin Liu; Qijun Wu; Shuang Zhang; Zhihong Wang; Hong Liu; Lanbo Teng; Ping Xiao; Yan Lu; Xuena Wang; Cui Dong; Jia Xiao; Jiayu Zhang
Journal:  BMC Nephrol       Date:  2022-01-03       Impact factor: 2.388

8.  Axicabtagene ciloleucel in non-Hodgkin lymphoma: the restricted mean survival time as a tool for estimating progression-free life expectancy better than the median.

Authors:  Andrea Messori; Marco Chiumente; Daniele Mengato
Journal:  Ther Adv Med Oncol       Date:  2020-06-03       Impact factor: 8.168

9.  Delayed hospital admission and high-dose corticosteroids potentially prolong SARS-CoV-2 RNA detection duration of patients with COVID-19.

Authors:  Zhigang Hu; Sijia Li; Ailan Yang; Wenxin Li; Xiaoqi Xiong; Jianwu Hu; Jun Jiang; Xinyu Song
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-29       Impact factor: 3.267

10.  An Older Thrombus Delays Reperfusion after Mechanical Thrombectomy for Ischemic Stroke.

Authors:  Takaya Kitano; Yumiko Hori; Shuhei Okazaki; Yuki Shimada; Takanori Iwamoto; Hideaki Kanki; Shintaro Sugiyama; Tsutomu Sasaki; Hajime Nakamura; Naoki Oyama; Taku Hoshi; Goichi Beck; Hiroki Takai; Shunji Matsubara; Hiroya Mizuno; Hirotake Nishimura; Ryo Tamaki; Junichi Iida; Jiro Iba; Masaaki Uno; Haruhiko Kishima; Hiroaki Fushimi; Satoshi Hattori; Shigeo Murayama; Eiichi Morii; Manabu Sakaguchi; Yoshiki Yagita; Takeshi Shimazu; Hideki Mochizuki; Kenichi Todo
Journal:  Thromb Haemost       Date:  2021-07-06       Impact factor: 6.681
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.